(AVNT) Avient - Overview

Sector: Basic Materials | Industry: Specialty Chemicals | Exchange: NYSE (USA) | Market Cap: 2.993m USD | Total Return: -2% in 12m

Polymer Formulations, Color Concentrates, Specialty Inks, Additives
Total Rating 41
Safety 77
Buy Signal -0.34
Specialty Chemicals
Industry Rotation: -2.6
Market Cap: 2.99B
Avg Turnover: 24.1M
Risk 3d forecast
Volatility33.8%
VaR 5th Pctl5.58%
VaR vs Median0.05%
Reward TTM
Sharpe Ratio-0.02
Rel. Str. IBD21.9
Rel. Str. Peer Group19.7
Character TTM
Beta1.132
Beta Downside1.435
Hurst Exponent0.655
Drawdowns 3y
Max DD46.87%
CAGR/Max DD-0.02
CAGR/Mean DD-0.04
EPS (Earnings per Share) EPS (Earnings per Share) of AVNT over the last years for every Quarter: "2021-03": 0.89, "2021-06": 0.87, "2021-09": 0.7, "2021-12": 0.58, "2022-03": 0.99, "2022-06": 0.97, "2022-09": 0.59, "2022-12": 0.39, "2023-03": 0.63, "2023-06": 0.63, "2023-09": 0.57, "2023-12": 0.52, "2024-03": 0.76, "2024-06": 0.76, "2024-09": 0.65, "2024-12": 0.49, "2025-03": 0.76, "2025-06": 0.57, "2025-09": 0.7, "2025-12": 0.56, "2026-03": 0.83,
EPS CAGR: 5.45%
EPS Trend: 70.8%
Last SUE: 0.94
Qual. Beats: 1
Revenue Revenue of AVNT over the last years for every Quarter: 2021-03: 1162.3, 2021-06: 1235.2, 2021-09: 818, 2021-12: 1201.5, 2022-03: 892.2, 2022-06: 891, 2022-09: 823.3, 2022-12: 790.4, 2023-03: 845.7, 2023-06: 824.4, 2023-09: 753.7, 2023-12: 719, 2024-03: 829, 2024-06: 849.7, 2024-09: 815.2, 2024-12: 746.5, 2025-03: 826.6, 2025-06: 866.5, 2025-09: 806.5, 2025-12: 760.6, 2026-03: 847.4,
Rev. CAGR: 0.89%
Rev. Trend: 48.0%
Last SUE: 0.10
Qual. Beats: 0

Warnings

Below Avwap Earnings

Tailwinds

No distinct edge detected

Description: AVNT Avient

Avient Corporation (NYSE: AVNT) is a global provider of specialized polymer materials, operating through two primary segments: Color, Additives and Inks, and Specialty Engineered Materials. The company develops custom-formulated solutions, including liquid systems, specialty inks, and thermoplastic concentrates, serving diverse end markets such as healthcare, food packaging, and transportation. Formerly known as PolyOne Corporation, the Ohio-based company rebranded in 2020 to reflect its shift toward high-margin specialty solutions.

The specialty chemicals sector is characterized by high barriers to entry due to the technical expertise required to meet rigorous regulatory standards in medical and food-grade applications. Avient utilizes a direct-to-customer business model, leveraging technical sales teams to provide engineered formulations tailored to specific performance requirements. Further analysis of these market dynamics is available on ValueRay for those conducting deeper due diligence. Founded in 1885, the company maintains an extensive international footprint with operations across North America, Europe, South America, and Asia.

Headlines to Watch Out For
  • Shift toward high-margin medical and pharmaceutical material applications drives earnings growth
  • Global consumer packaging demand fluctuations impact specialty ink and additive volumes
  • Raw material cost volatility for specialty polymers affects consolidated operating margins
  • Industrial and construction sector cyclicality influences specialty engineered materials revenue performance
  • Strategic portfolio shift toward specialty solutions reduces exposure to commodity price swings
Piotroski VR-10 (Strict) 7.0
Net Income: 157.8m TTM > 0 and > 6% of Revenue
FCF/TA: 0.03 > 0.02 and ΔFCF/TA 1.07 > 1.0
NWC/Revenue: 18.92% < 20% (prev 22.61%; Δ -3.69% < -1%)
CFO/TA 0.05 > 3% & CFO 318.2m > Net Income 157.8m
Net Debt (1.57b) to EBITDA (531.8m): 2.96 < 3
Current Ratio: 1.77 > 1.5 & < 3
Outstanding Shares: last quarter (91.9m) vs 12m ago 0.44% < -2%
Gross Margin: 31.74% > 18% (prev 0.32%; Δ 3.14k% > 0.5%)
Asset Turnover: 55.82% > 50% (prev 55.72%; Δ 0.10% > 0%)
Interest Coverage Ratio: 3.07 > 6 (EBITDA TTM 531.8m / Interest Expense TTM 111.8m)
Altman Z'' 2.65
A: 0.10 (Total Current Assets 1.42b - Total Current Liabilities 803.1m) / Total Assets 5.94b
B: 0.32 (Retained Earnings 1.90b / Total Assets 5.94b)
C: 0.06 (EBIT TTM 343.3m / Avg Total Assets 5.88b)
D: 0.51 (Book Value of Equity 1.79b / Total Liabilities 3.53b)
Altman-Z'' = 2.65 = A
Beneish M -3.00
DSRI: 1.03 (Receivables 513.4m/489.6m, Revenue 3.28b/3.24b)
GMI: 1.01 (GM 31.74% / 32.17%)
AQI: 1.01 (AQ_t 0.60 / AQ_t-1 0.59)
SGI: 1.01 (Revenue 3.28b / 3.24b)
TATA: -0.03 (NI 157.8m - CFO 318.2m) / TA 5.94b)
Beneish M = -3.00 (Cap -4..+1) = A
What is the price of AVNT shares?

As of May 24, 2026, the stock is trading at USD 34.31 with a total of 476,816 shares traded.
Over the past week, the price has changed by +1.60%, over one month by -7.89%, over three months by -17.87% and over the past year by -1.96%.

Is AVNT a buy, sell or hold?

Avient has received a consensus analysts rating of 4.33. Therefore, it is recommended to buy AVNT.

  • StrongBuy: 4
  • Buy: 0
  • Hold: 2
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the AVNT price?
Analysts Target Price 48.1 40.3%
Avient (AVNT) - Fundamental Data Overview as of 21 May 2026
P/E Trailing = 18.9767
P/E Forward = 10.9409
P/S = 0.9123
P/B = 1.2873
P/EG = 1.0947
Revenue TTM = 3.28b USD
EBIT TTM = 343.3m USD
EBITDA TTM = 531.8m USD
Long Term Debt = 1.92b USD (from longTermDebt, last quarter)
Short Term Debt = 500k USD (from shortTermDebt, last quarter)
Debt = 2.00b USD (from shortLongTermDebtTotal, last quarter) + Leases 77.3m
Net Debt = 1.57b USD (calculated: Debt 2.00b - CCE 427.6m)
Enterprise Value = 4.57b USD (2.99b + Debt 2.00b - CCE 427.6m)
Interest Coverage Ratio = 3.07 (Ebit TTM 343.3m / Interest Expense TTM 111.8m)
EV/FCF = 22.27x (Enterprise Value 4.57b / FCF TTM 205.1m)
FCF Yield = 4.49% (FCF TTM 205.1m / Enterprise Value 4.57b)
FCF Margin = 6.25% (FCF TTM 205.1m / Revenue TTM 3.28b)
Net Margin = 4.81% (Net Income TTM 157.8m / Revenue TTM 3.28b)
Gross Margin = 31.74% ((Revenue TTM 3.28b - Cost of Revenue TTM 2.24b) / Revenue TTM)
Gross Margin QoQ = 32.17% (prev 32.34%)
Tobins Q-Ratio = 0.77 (Enterprise Value 4.57b / Total Assets 5.94b)
Interest Expense / Debt = 5.58% (Interest Expense 111.8m / Debt 2.00b)
Taxrate = 22.82% (16.5m / 72.3m)
NOPAT = 265.0m (EBIT 343.3m * (1 - 22.82%))
Current Ratio = 1.77 (Total Current Assets 1.42b / Total Current Liabilities 803.1m)
Debt / Equity = 0.83 (Debt 2.00b / totalStockholderEquity, last quarter 2.41b)
Debt / EBITDA = 2.96 (Net Debt 1.57b / EBITDA 531.8m)
Debt / FCF = 7.68 (Net Debt 1.57b / FCF TTM 205.1m)
Total Stockholder Equity = 2.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.68% (Net Income 157.8m / Total Assets 5.94b)
RoE = 6.64% (Net Income TTM 157.8m / Total Stockholder Equity 2.38b)
RoCE = 7.98% (EBIT 343.3m / Capital Employed (Equity 2.38b + L.T.Debt 1.92b))
RoIC = 5.19% (NOPAT 265.0m / Invested Capital 5.11b)
WACC = 7.70% (E(2.99b)/V(5.00b) * Re(9.96%) + D(2.00b)/V(5.00b) * Rd(5.58%) * (1-Tc(0.23)))
Discount Rate = 9.96% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -26.26 | Cagr: 0.0%
[DCF] Terminal Value 77.97% ; FCFF base≈178.5m ; Y1≈204.6m ; Y5≈301.1m
[DCF] Fair Price = 32.24 (EV 4.53b - Net Debt 1.57b = Equity 2.96b / Shares 91.7m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 70.78 | EPS CAGR: 5.45% | SUE: 0.94 | # QB: 1
Revenue Correlation: 47.96 | Revenue CAGR: 0.89% | SUE: 0.10 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.89 | Chg30d=+0.64% | Revisions=+11% | Analysts=6
EPS next Quarter (2026-09-30): EPS=0.74 | Chg30d=-0.59% | Revisions=+0% | Analysts=6
EPS current Year (2026-12-31): EPS=3.07 | Chg30d=+0.27% | Revisions=+25% | GrowthEPS=+9.0% | GrowthRev=+3.4%
EPS next Year (2027-12-31): EPS=3.38 | Chg30d=+0.04% | Revisions=+0% | GrowthEPS=+10.2% | GrowthRev=+3.6%
[Analyst] Revisions Ratio: +25%